Decreased expression and novel mutation of HYAL1 in patients with non-small cell lung cancer

被引：0
|
作者：
He, J [1 ]
Zhang, C [1 ]
Hang, J [1 ]
Shao, K [1 ]
机构：
[1] CAMS, Canc Hosp Inst, Beijing, Peoples R China
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [1] A newly identified mutation in the HYAL1 gene correlates with tumor growth and vascular invasion in patients with non-small cell lung cancer (NSCLC)
    Zhang, CY
    He, J
    Hang, J
    Shao, K
    Zhang, S
    Mu, XH
    Shi, SS
    Wang, W
    Feng, XL
    Rayburn, E
    Wang, H
    ONCOLOGY RESEARCH, 2006, 15 (10-12) : 475 - 476
  • [2] Decreased FAM107A Expression in Patients with Non-small Cell Lung Cancer
    Pastuszak-Lewandoska, D.
    Czarnecka, K. H.
    Migdalska-Sek, M.
    Nawrot, E.
    Domanska, D.
    Kiszalkiewicz, J.
    Kordiak, J.
    Antczak, A.
    Gorski, P.
    Brzezianska-Lasota, E.
    RESPIRATORY CARCINOGENESIS, 2015, 852 : 39 - 48
  • [3] Identification of a novel MUTYH mutation in non-small cell lung cancer
    Fong, Alvin Hong-Wai
    Lau, Eunice Yuen-Ting
    Cheung, William Ka-Chun
    Cho, William Chi-Shing
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Understanding BRAF mutation in non-small cell lung cancer patients
    Tine, Mariaenrica
    Squarzoni, Giulia
    Ortolan, Davide
    Pezzuto, Federica
    Calabrese, Fiorella
    Squarzoni, Giulia
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Downregulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1, and HYAL2 in non-small cell lung cancer
    Anedchenko, E. A.
    Dmitriev, A. A.
    Krasnov, G. S.
    Kondrat'eva, O. O.
    Kopantsev, E. P.
    Vinogradova, T. V.
    Zinov'eva, M. V.
    Zborovskaya, I. B.
    Polotsky, B. E.
    Sacharova, O. V.
    Kashuba, V. I.
    Zabarovsky, E. R.
    Senchenko, V. N.
    MOLECULAR BIOLOGY, 2008, 42 (06) : 859 - 869
  • [6] Decreased SARI expression predicts poor prognosis of Chinese patients with non-small cell lung cancer
    Zhou, Ren-Jie
    Shi, Zhong
    Zhou, Kun
    Wang, Hai-Dong
    Zhang, Guo-Qiang
    Li, Xue-Tao
    Xu, Jian-Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (10): : 2056 - 2063
  • [7] Downregulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1, and HYAL2 in non-small cell lung cancer
    E. A. Anedchenko
    A. A. Dmitriev
    G. S. Krasnov
    O. O. Kondrat’eva
    E. P. Kopantsev
    T. V. Vinogradova
    M. V. Zinov’eva
    I. B. Zborovskaya
    B. E. Polotsky
    O. V. Sacharova
    V. I. Kashuba
    E. R. Zabarovsky
    V. N. Senchenko
    Molecular Biology, 2008, 42 : 859 - 869
  • [8] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
  • [9] DETECTING EGFR MUTATION AND ITS LIGANDS EXPRESSION IN ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS
    Wang, S.
    Han, X.
    Li, J.
    Hu, X.
    Wang, X.
    Gui, L.
    Zhao, L.
    Sun, Y.
    Shi, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 394 - 394
  • [10] Association of mutation profiles with metastasis in patients with non-small cell lung cancer
    Li, Yingxue
    Zheng, Zheng
    Wang, Li
    Han, Lin
    Du, Ying
    Zhang, Xuedong
    Liu, Xia
    Xie, Jiaping
    FRONTIERS IN ONCOLOGY, 2024, 14
12345